HEALTHFINANCIAL TIMES WORLD
Dr Reddy’s runs into trouble with its weight-loss drug
Dr Reddy’s is facing issues with its weight-loss drug. The UK-India trade deal is set to begin this week.
Related Signal
Adjacent reporting
- Brazil’s Weight-Loss Drug Market Enters a Price War
- Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
- Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
- Insurance increasingly dropping weight loss drugs like Wegovy, Zepbound
- STAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug